|
Aug 6
|
Senseonics Holdings, Inc. Reports Second Quarter Financial Results
|
|
Aug 6
|
Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It?
|
|
Aug 6
|
Abbott Laboratories' (NYSE:ABT) Earnings Are Of Questionable Quality
|
|
Aug 6
|
Medical Devices & Supplies - Diversified Stocks Q2 Highlights: Abbott Laboratories (NYSE:ABT)
|
|
Aug 4
|
QuidelOrtho Corporation (QDEL): A Bull Case Theory
|
|
Aug 4
|
Abbott Laboratories (NYSE:ABT) Is Looking To Continue Growing Its Returns On Capital
|
|
Aug 1
|
2 Top Stocks to Buy Now If You Want Decades of Passive Income
|
|
Jul 31
|
AbbVie’s (NYSE:ABBV) Q2: Beats On Revenue
|
|
Jul 31
|
UBS Shrugs Abbott Laboratories’ (ABT) Diagnostic Weakness Affirms ‘Buy’ Rating
|
|
Jul 30
|
Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic
|
|
Jul 29
|
Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report
|
|
Jul 29
|
A new infant formula seven years in the making is hitting the $2 billion market
|
|
Jul 29
|
Europe Defibrillator Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Philips, Nihon Kohden, Boston Scientific, Stryker, Asahi Kasei, LivaNova, and Abbott
|
|
Jul 29
|
North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers
|
|
Jul 29
|
Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche
|
|
Jul 28
|
Revvity trims 2025 profit forecast as China policy changes hit diagnostics demand
|
|
Jul 28
|
Leerink Partners Decreases PT on Abbott Laboratories (ABT) to $136 From $143, Maintains a Hold Rating
|
|
Jul 28
|
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)
|
|
Jul 27
|
A Data Deluge Brings a ‘Moment of Truth’ for Markets This Week
|
|
Jul 27
|
Declining Stock and Solid Fundamentals: Is The Market Wrong About Abbott Laboratories (NYSE:ABT)?
|